1.Clinical and genetic analysis of a Chinese pedigree affected with Smith-Lemli-Opitz syndrome.
Chao GAO ; Jiali DUAN ; Pei ZHANG ; Yang GAO ; Yanmin ZHANG ; Yanli WANG ; Shuang AN ; Jiaojiao HUANG
Chinese Journal of Medical Genetics 2020;37(11):1272-1275
OBJECTIVE:
To explore the clinical phenotype and pathogenic variants in a Chinese pedigree affected with Smith-Lemli-Opitz syndrome.
METHODS:
Peripheral blood samples were collected from five members, including two affected ones, from the pedigree for the extraction of genomic DNA. Whole exome sequencing was carried out, and candidate variants were verified by Sanger sequencing as well as reverse transcription sequencing at the RNA level.
RESULTS:
The proband and another affected child from the pedigree showed mental retardation, dyskinesia, microcephaly, micrognathia, anteverted nares, and 2/3 toe syndactyly. The proband also had hypospadia, single upper incisor, and lower serum cholesterol level. Both children were found to harbor a paternally derived c.278C>T (p.T93M) variant and a maternally derived c.907G>A (p.G303R) variant of the DHCR7 gene. Both were known pathogenic mutations.
CONCLUSION
The compound heterozygous mutations of c.278C>T (p.T93M) and c.907G>A (p.G303R) of the DHCR7 gene probably underlay the disease in this pedigree. Above finding has enabled early diagnosis and treatment of Smith-Lemli-Opitz syndrome.
Child
;
Genetic Testing
;
Humans
;
Oxidoreductases Acting on CH-CH Group Donors/genetics*
;
Pedigree
;
Phenotype
;
Smith-Lemli-Opitz Syndrome/genetics*
2.Clinical features and genetic testing of a Chinese pedigree affected with Smith-Lemli-Opitz syndrome.
Fengyu CHE ; Chunxia HE ; Liyu ZHANG ; Xiaopeng GAO ; Yarong LI ; Ying YANG
Chinese Journal of Medical Genetics 2021;38(11):1114-1119
OBJECTIVE:
To analyze the clinical features and genetic variants of two patients from a pedigree affected with Smith-Lemli-Opitz syndrome and explore their genotype-phenotype correlation.
METHODS:
Clinical data and family history of the pedigree were collected. Whole exome sequencing was carried out to identify the potential variants. Suspected variants were verified by Sanger sequencing of the family members.
RESULTS:
The proband and her sister both presented with feeding difficulty, facial dysmorphism, seizures, and mental and speech retardation. The third child of this family presented with feeding difficulty, poor weight gain and severe malnutrition after birth. He had died of unknown cause at 6 months without genetic testing. The fourth child was a healthy boy. Genetic testing showed that both the proband and her sister have carried c.127G>T (p.Val43Phe) and c.820_825del (p.Asn274_Val275del) compound heterozygous variants of the DHCR7 gene (NM_001360.2), but the fourth child carried neither of the variants. The two variants were unreported in the literature and disease-related databases, and were not included in the 1000G and gnomAD databases. The c.820_825del variant may affect the sterol-sensitive region of the DHCR7 protein, which can lead to deletion of two amino acids at positions 247 and 275, causing truncation of the DHCR7 protein. It is speculated that this may affect the stability of protein's spatial conformation, thereby decrease the activity of the enzyme. The c.127G>T variant may affect the first transmembrane region of the protein, which is involved in the transmembrane transport of proteins. Multiple software predicted it to be harmful. Conservation analysis suggested that the three amino acids all locate in a highly conserved region of the protein. In consideration of the clinical phenotype, family history and result of genetic testing, we speculated that both patients had Smith-Lemli-Opitz syndrome due to variants of the DHCR7 gene.
CONCLUSION
This pedigree has enriched the phenotypic and genotypic data of Smith-Lemli-Opitz syndrome, which clarified the genetic etiology of the patients and provided a basis for genetic counseling of this pedigree.
China
;
Female
;
Genetic Testing
;
Humans
;
Male
;
Mutation
;
Oxidoreductases Acting on CH-CH Group Donors/genetics*
;
Pedigree
;
Smith-Lemli-Opitz Syndrome/genetics*
3.A Novel DHCR7 Mutation in a Smith-Lemli-Opitz Syndrome Infant Presenting with Neonatal Cholestasis.
Jae Sung KO ; Byung Sam CHOI ; Jeong Kee SEO ; Jee Yeon SHIN ; Jong Hee CHAE ; Gyeong Hoon KANG ; Ran LEE ; Chang Seok KI ; Jong Won KIM
Journal of Korean Medical Science 2010;25(1):159-162
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive malformation syndrome caused by a defect in cholesterol biosynthesis. The incidence is very low in Asians and only one case has been reported in Korea thus far. Recently, we found an infant with neonatal cholestasis. He had microcephaly, ambiguous genitalia, cleft palate, syndactyly of toes, patent ductus arteriosus and hypertrophic pyloric stenosis. The serum cholesterol was decreased and serum 7-dehydrocholesterol was markedly elevated. Genetic analysis of the DHCR7 gene identified a novel missense mutation (Pro227Ser) as well as a known mutation (Gly303Arg) previously identified in a Japanese patient with SLOS. Although rare in Korea, SLOS should be considered in the differential diagnosis of neonatal cholestasis, especially in patients with multiple congenital anomalies and low serum cholesterol levels.
Amino Acid Substitution
;
Base Sequence
;
Cholestasis/*diagnosis
;
Ductus Arteriosus, Patent/diagnosis
;
Electroencephalography
;
Humans
;
Infant, Newborn
;
Liver/pathology/ultrasonography
;
Male
;
*Mutation, Missense
;
Oxidoreductases Acting on CH-CH Group Donors/*genetics
;
Phenotype
;
Smith-Lemli-Opitz Syndrome/diagnosis/*genetics